Showing results (31-40 of 342) with videos related to
Sort By:
Pageof 35
The Journal of Headache and Pain|October 9, 2010
Are the current IHS guidelines for migraine drug trials being followed?Anders Hougaard, Peer Tfelt-HansenThe Journal of Headache and Pain|March 31, 2009
Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A reviewPeer Tfelt-Hansen, Han LeExpert Opinion on Drug Metabolism & Toxicology|June 23, 2015
Review of dose-response curves for acute antimigraine drugs: triptans, 5-HT1F agonists and CGRP antagonistsAnders Hougaard, Peer Tfelt-HansenHeadache|September 7, 2016
Is the Generally Held View That Intravenous Dihydroergotamine Is Effective in Migraine Based on Wrong "General Consensus" of One Trial? A Critical Review of the Trial and Subsequent QuotationsGoran Bekan, Peer Tfelt-HansenUgeskrift for Laeger|October 1, 2008
[Numbness of the chin as a paraneoplastic syndrome]Cornelia Rogojan, Peer Tfelt-HansenExpert Opinion on Drug Metabolism & Toxicology|December 12, 2012
Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migrainePeer Tfelt-Hansen, Anders HougaardCephalalgia : an International Journal of Headache|November 11, 2015
General lack of use of placebo in prophylactic, randomised, controlled trials in adult migraine. A systematic reviewAnders Hougaard, Peer Tfelt-HansenCurrent Opinion in Neurology|May 3, 2008
Acute migraine therapy: recent evidence from randomized comparative trialsAnna Mett, Peer Tfelt-HansenUgeskrift for Laeger|February 14, 2013
[The most important question in diagnosing cluster headache is the duration of the extremely severe headache]Rigmor Jensen, Peer Tfelt-HansenThe Journal of Headache and Pain|January 25, 2008
Pharmacogenomics and migraine: possible implicationsPeer Tfelt-Hansen, Kim BrøsenPageof 35